Signs point to biotech M&A heating up, Wells Fargo says. Here’s where to look

"Big BioPharma needs growth," says Wells Fargo analyst Mohit Bansal in a research note that anticipates a pick-up in smaller

Read more

Searching for value in the battered biotech sector, which may not have hit bottom yet

Amid the market turmoil, a growing number of biotech stocks are now trading below the value of the cash on

Read more